PLEASE NOTE THE UNUSUAL DAY AND TIME OF THIS TALK. IT WILL TAKE PLACE IN THE MERRISON LECTURE THEATRE AT DARESBURY LABORATORY AND ALSO BE BROADCAST VIA ZOOM.
In this talk, I will present the initial LCLS-II commissioning results and some lessons learned along the way. The injector and all 35 cryomodules have been operating stably for over a year up to 3.5 GeV. Starting this month (October...
After 25 years of successful research in the nuclear and radiation physics domain, the KVI-CART research center in Groningen has been upgraded and re-established as the PARticle Therapy REsearch Center (PARTREC). Using the superconducting cyclotron AGOR and being embedded within the University Medical Center Groningen, it operates in close collaboration with the Groningen Proton Therapy...
CERN-MEDICIS produces radionuclides by mass separation for biomedical research. The facility exploits targets either irradiated with PS Booster high-energy proton beam or irradiated at cyclotrons and in research nuclear reactors at partner institutes that are part of the MEDICIS Collaboration.The facility extends isotope mass separation techniques towards the reliable and efficient production...
